Hayley French
Director Ejecutivo en Apitope International NV .
Perfil
Hayley French is currently the Director, Chief Executive & Operating Officer at Apitope International NV.
She previously worked as a Principal at Bird & Bird LLP, Head-Commercial Legal Affairs at the Health Protection Agency, and Principal at Novartis Pharma NV.
She also served as the President of the Licensing Executives Society Britain & Ireland.
Dr. French completed her undergraduate degree at The University of Liverpool and holds graduate and doctorate degrees from the University of London.
Cargos activos de Hayley French
| Empresas | Cargo | Inicio |
|---|---|---|
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Director Ejecutivo | 24/10/2018 |
Antiguos cargos conocidos de Hayley French.
| Empresas | Cargo | Fin |
|---|---|---|
| Licensing Executives Society Britain & Ireland | Presidente | - |
Bird & Bird LLP
 Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Bird & Bird LLP provide legal services. The firm focuses on aviation and aerospace, banking and financial services, communications, eCommerce, information technology, life sciences, media, and sports sectors. The company was founded in 1846 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Health Protection Agency | Consejero General | - |
Novartis Pharma NV
 Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Corporate Officer/Principal | - |
Formación de Hayley French.
| The University of Liverpool | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Health Technology |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Health Technology |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Bird & Bird LLP provide legal services. The firm focuses on aviation and aerospace, banking and financial services, communications, eCommerce, information technology, life sciences, media, and sports sectors. The company was founded in 1846 and is headquartered in London, the United Kingdom. | Commercial Services |
| Health Protection Agency | Government |
| Licensing Executives Society Britain & Ireland |
- Bolsa de valores
- Insiders
- Hayley French
